Jeffrey M. Dayno insider trades: Harmony Biosciences Holdings (HRMY) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jeffrey reports to the SEC
Open-market buys and sales
19 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | HRMY | ↓ Sell | 25,933 | $40.11 | $1.0M | Direct | Dec 17, 2025 (5d) |
| Jan 21, 2025 | HRMY | ↓ Sell | 19,293 | $40.13 | $774K | Direct | Jan 23, 2025 (2d) |
| Nov 3, 2022 | HRMY | ↓ Sell | 15,000 | $60.02 | $900K | Direct | Nov 4, 2022 (1d) |
| Nov 1, 2022 | HRMY | ↓ Sell | 15,000 | $55.10 | $827K | Direct | Nov 2, 2022 (1d) |
| Oct 19, 2021 | HRMY | ↓ Sell | 18,200 | $43.27 | $788K | Direct | Oct 20, 2021 (1d) |
| Oct 6, 2021 | HRMY | ↓ Sell | 1,800 | $40.10 | $72K | Direct | Oct 7, 2021 (1d) |
| Sep 7, 2021 | HRMY | ↓ Sell | 10,000 | $37.58 | $376K | Direct | Sep 9, 2021 (2d) |
| Aug 27, 2021 | HRMY | ↓ Sell | 10,000 | $35.13 | $351K | Direct | Aug 30, 2021 (3d) |
| Aug 10, 2021 | HRMY | ↓ Sell | 9,950 | $30.21 | $301K | Direct | Aug 11, 2021 (1d) |
| Jul 22, 2021 | HRMY | ↓ Sell | 50 | $30.00 | $2K | Direct | Jul 23, 2021 (1d) |
| Mar 31, 2017 | EGLT | ↓ Sell | 536 | $5.16 | $3K | Direct | Apr 4, 2017 (4d) |
| Jan 3, 2017 | EGLT | ↓ Sell | 536 | $7.75 | $4K | Direct | Jan 4, 2017 (1d) |
| Sep 30, 2016 | EGLT | ↓ Sell | 536 | $7.69 | $4K | Direct | Oct 3, 2016 (3d) |
| Jun 30, 2016 | EGLT | ↓ Sell | 536 | $4.65 | $2K | Direct | Jul 5, 2016 (5d) |
| Mar 31, 2016 | EGLT | ↓ Sell | 536 | $6.72 | $4K | Direct | Apr 4, 2016 (4d) |
| Dec 31, 2015 | EGLT | ↓ Sell | 536 | $10.40 | $6K | Direct | Jan 5, 2016 (5d) |
| Oct 26, 2015 | EGLT | ↓ Sell | 536 | $8.96 | $5K | Direct | Oct 28, 2015 (2d) |
| Jun 30, 2015 | EGLT | ↓ Sell | 536 | $15.32 | $8K | Direct | Jul 2, 2015 (2d) |
| Feb 3, 2015 | EGLT | ↓ Sell | 2,500 | $8.87 | $22K | Direct | Feb 3, 2015 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other HRMY insiders
Open-market trades in the last 12 months
About Jeffrey M. Dayno's insider trades
Jeffrey M. Dayno is President, CEO at Harmony Biosciences Holdings (HRMY). Since Feb 3, 2015, Jeffrey has reported no open-market purchases and 19 sales worth $5.5M on SEC Form 4. In the last 12 months: 1 sale ($1.0M).
Their filings also include option exercises (11 filings), grants and awards (9 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HRMY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.